Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03856515 · ClinicalTrials.gov registry record · NA

Gender Differences in Switching From Smoking Regular Cigarettes to E-Cigarettes

A NA study of Cigarette Smoking-Related Carcinoma, sponsored by M.D. Anderson Cancer Center.

Completed
Registry status
NA
Development phase
169
Enrollment target
1
Study location

NCT03856515 is a NA study of Cigarette Smoking-Related Carcinoma that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 169 participants, below the 459-participant average among 21 other Cigarette Smoking-Related Carcinoma trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03856515, a NA study of Cigarette Smoking-Related Carcinoma, has completed, sponsored by M.D. Anderson Cancer Center.

COMPLETED
Registry status
NA
Development phase
169 participants
Enrollment target
1
Study location

Study Summary

This early phase I trial studies potential differences between men and women when switching from the use of combustible cigarettes to the National Institute on Drug Abuse's Standard Research E-Cigarette (SREC). Studying the differences between men and women may increase understanding about the effects of switching from smoking regular cigarettes to electronic cigarettes.

Interventions

  • OTHER Questionnaire Administration
  • DRUG Nicotine Replacement
  • DEVICE Electronic Cigarette

Study Locations (1)

Texas

  • M D Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 169 participants
Start Date 2022-06-02
Est. Completion 2026-01-07
Phase NA

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT03856515

The ClinicalTrials.gov registry entry for NCT03856515 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 169 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 459-participant average among 21 other Cigarette Smoking-Related Carcinoma trials with a reported enrollment target (63% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cigarette Smoking-Related Carcinoma appearing as the primary indexed condition, and to 3 interventions - of which Questionnaire Administration is the first listed.

NCT03856515 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT03856515 about?

NCT03856515 is a clinical study titled "Gender Differences in Switching From Smoking Regular Cigarettes to E-Cigarettes". This early phase I trial studies potential differences between men and women when switching from the use of combustible cigarettes to the National Institute on Drug Abuse's Standard Research E-Cigarette (SREC). Studying the differences between men and women may increase understanding about the effec...

What is the current status of trial NCT03856515?

This trial is currently completed. It is a NA study. The enrollment target is 169 participants. The study started on 2022-06-02. Estimated completion is 2026-01-07.

What conditions does trial NCT03856515 study?

This clinical trial studies the following conditions: Cigarette Smoking-Related Carcinoma.

What interventions are being tested in trial NCT03856515?

The interventions under investigation include: Questionnaire Administration (OTHER), Nicotine Replacement (DRUG), Electronic Cigarette (DEVICE).

Who is sponsoring clinical trial NCT03856515?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03856515 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cigarette Smoking-Related Carcinoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.